Document Page: First | Prev | Next | All | Image | This Release | Search
File: doc17_05.txt
~Oll OFFICIAL ~~~E ONL7
ANNEX D
(Use of Pyridostigmine Tablets) to Operation Desert Storm NBC SOP
1. Pyridostiqmine, if taken prior t~ a nerve agent chemical
attack, greatly enhances the effectiveness of subsequent nerve
agent antidote treatment. Although it is a very important part
of a soldier1 S defense against a nerve agent attack, it is
important to emphasize that it is noL tc) be used for treatment of
a chemical casualty, and it will not prevent the effects of nerve
agent from occurring.
2. Pyridostigmine tablets are issued aC; a blister pack
containing 21 tablets. They are an individual issue item.
Personnel may draw them from the CCH NBC room if needed.
3. The Headquarters Commandant, (in coordination with CCJ2,
CCJ3, CCJ3-X, and CCSG) will make a recommendation to the
USCENTCOM Chief of Staff when it is Lime for personnel to start
taking the pyridostigmine tablets. `rhe CCCS will direct
personnel assigned to HQ USCENTCOM wi en to start taking
pyridostigmine.
4. The dose is one tablet, taken by mo~th, every eight hours.
If a dose is missed, under no circum~tances should a soldier take
two tablets as a "make up" dose. In.~tead, the soldier should
take one tablet and restart the eight hour schedule.
5. MOPP IV integrity will not be br~ken in order to ta)c~ the
tablets, personnel will wait until t:~e MOPP IV condition is
reduced.
6. Every three days CCCS will reass~ss the need for taking
pyridostigmine. Personnel will not take pyridostigmine for
longer than seven consecutive days u:~less directed to do so by
the CCCS due to a continued threat o~ nerve agent attack.
7. Approximately 1 in 1,000 personnel will experience side
effects associated with use of pyridostigmine (ie. stomach
irritability and minor skin rashes). However, there is no
decrement in mental or physical performance.
r `L'i~ `u'r r &UiAt~ U~iS `Jf~I
BES~fl~Q7 A~ ~LAS~1FiLD Wr~~E
10
DOWNGRADED FOR RELEASE 12 JAN 96
USCENTCOM HQCC
Document Page: First | Prev | Next | All | Image | This Release | Search